![](/img/cover-not-exists.png)
815PDA PHASE I/II TRIAL OF BNC105P WITH EVEROLIMUS IN METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS OF THE RANDOMIZED PHASE II DISRUPTOR-1 TRIAL
Pal, S., Azad, A., Bhatia, S., Drabkin, H., Costello, B., Sarantopolous, J., Kanesvaran, R., Lauer, R., Sweeney, C., Hahn, N.M., Sonpavde, G., Richey, S., Breen, T., Kremmidiotis, G., Doolin, E., BibbVolume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu337.8
Date:
September, 2014
File:
PDF, 68 KB
2014